Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2020-10-24
2021-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of Intraperitoneal Instillation of Fentanyl Versus Nalbuphine As Adjuvants to Bupivacaine for Postoperative Pain Relief in Patients Undergoing Laparoscopic Cholecystectomy
NCT06722963
Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection
NCT05674877
Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University
NCT04223219
Opioid Free Anesthesia vs. Opioid Anesthesia Techniques.
NCT03367988
Multimodal and Unimodal Analgesia in Cholecystectomy
NCT05547659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G-M
Received classic general Anesthesia, intrathecal (Bupivacaine 15 mg, morphine 4 microgram/kg) plus saline infusion intraoperative and postoperative.
Morphine Sulfate
intrathecal morphine will be added to anaesthetics
G-ML
Received classic general Anesthesia, intrathecal morphine in a dose of 4 microgram/kg, and intravenous lidocaine in a loading dose of 1.5 mg/kg, then 2 mg/min with the saline infusion over the time of the operation and the next 4 hours postoperative.
morphine+lidocaine
local anesthetic will be infused intravenously
G-0
Received General Anesthesia and Spinal anesthesia as previously described with saline infusion in the same design as in the previous two groups.
Saline
intravenous saline infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morphine Sulfate
intrathecal morphine will be added to anaesthetics
morphine+lidocaine
local anesthetic will be infused intravenously
Saline
intravenous saline infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for abdominal surgeries
* Patients with American Society of Anesthesiologists (ASA) I, II physical status
Exclusion Criteria
* Critically ill patients.
* Patients who have contraindications to regional anesthesia.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esam Hamed
clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Esam A. Hamed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17300478
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.